Incyte Stock Forecast & Price Target
Incyte Price Target 2026
The Quantum Forecast sees a price target of $122.33 (+2.9%) for Incyte in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $118.85. Click to see the forecast in the chart.
Incyte Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Incyte at $118.69 (−0.13%) today around 10:30 AM ET and at $118.43 (−0.36%) today around 3:30 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Incyte Stock 2026: Price Performance
Incyte stock has gained 20.3% since the start of 2026 and currently trades at $118.85 (as of Nov 11, 2026). Over the same period the S&P 500 is up 10.9%, putting the stock 9.5 percentage points ahead of the index. Over the past 52 weeks the price ranged between $88.98 and $132.57; it is currently 10.3% below its high of Jul 28, 2026.
Incyte Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $131.86 for Incyte – +10.9% from today. The range band runs from $80.60 – $183.13: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Incyte
There are no user forecasts for Incyte yet – be the first to make one.
Make your own forecastAbout Incyte
Incyte is a biotechnology company based in Wilmington, Delaware, that develops medicines for cancer and inflammatory diseases. Its most important product is Jakafi (ruxolitinib), a JAK inhibitor used to treat myelofibrosis, polycythemia vera and graft-versus-host disease. Outside the United States, Novartis markets the drug as Jakavi and pays Incyte royalties. Opzelura, a cream containing the same active ingredient, is approved for atopic dermatitis and the skin condition vitiligo. Incyte was founded in 1991, originally as a genomics company.
Other medicines target certain lymphomas, bile duct cancer and skin cancer. Customers are hematologists, oncologists and dermatologists in the United States, Europe and Japan. Additional income comes from royalties, including on Eli Lilly's rheumatoid arthritis drug Olumiant. Because Jakafi's patent protection will eventually expire, Incyte is working to reduce its reliance on the drug, so the growth of Opzelura and pipeline progress are central themes for investors. Its shares trade on the Nasdaq under the symbol INCY and are included in the S&P 500.
The current price of Incyte stock is $118.85 (−1.64% vs. the previous close). In today's trading the high was $119.90 and the low $118.10.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Incyte Stock
What is the Incyte stock forecast?
The Quantum Forecast expects Incyte to reach $122.33 in about one month (by Dec 10, 2026), a change of +2.9% from the current price of $118.85. Over roughly 10 months (by Sep 2027) the price target is $131.86 (+10.9%).
What is the Incyte stock price target?
Quantum Forecast price targets by time frame: 1 month $122.33 (+2.9%), 2 months $108.83 (−8.4%), 6 months $120.18 (+1.1%), 10 months $131.86 (+10.9%). The range band shows the typical fluctuation around these targets.
Will Incyte stock go up or down?
In the short term the Quantum Forecast points up (+2.9% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Incyte?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.